Gelie Kuitong Pian (格列喹酮片)格列喹酮片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

格列喹酮是一种在国家药监局注册认定的药品。该药品含有格列喹酮-05c616bd等成分。

该药品关联的活性成分包括:格列喹酮Gelie Kuitong。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:杭州国光药业有限公司Chinese legal name: 杭州国光药业有限公司。

您可以探索含有相同成分的其他药品:格列喹酮-05c616bd成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 格列喹酮片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 格列喹酮Gelie Kuitong.

Manufacturers recorded for this product: 杭州国光药业有限公司Chinese legal name: 杭州国光药业有限公司.

Explore other medicines containing the same ingredient: 格列喹酮 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 格列喹酮片Recorded Chinese name: 格列喹酮片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 30mg30 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 杭州国光药业有限公司Chinese legal name: 杭州国光药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20123059

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20123059

Manufacturer

Chinese legal name: 杭州国光药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20123059

生产企业

杭州国光药业有限公司(国产)

适应症

本品用于2型糖尿病。

用法用量

1.餐前服用,根据患者个体情况,可适当调节剂量,一般日剂量为15~180mg。日剂量30mg以内者可于早餐前一次服用。大于此剂量者可酌情分为早、晚或早、中、晚分次服用。|2.开始治疗量应从15~30mg开始,根据血糖情况逐步加量,每次加量15~30mg,如原已服用其他磺酰脲类药改用本品时,可按相同量开始,按上述量逐渐加量调整,日最大剂量一般不超过180mg。

不良反应

极少数人有皮肤过敏反应、胃肠道反应、轻度低血糖反应及血液系统方面改变的报道。

禁忌

下列患者禁用:|1.1型糖尿病。|2.糖尿病昏迷或昏迷前期。|3.糖尿病合并酸中毒或酮症。|4.对磺胺类药物过敏者。|5.妊娠、哺乳期及晚期尿毒症患者。

注意事项

1.糖尿病患者合并肾脏疾病,肾功能轻度异常时,尚可使用。但是当有严重肾功能不全时,则应改用胰岛素治疗为宜。|2.治疗中若有不适,如低血糖、发热、皮疹、恶心等应从速就医。|3.改用本品时如未按时进食或过量用药都可以引起低血糖。|4.若发生低血糖,一般只需进食糖、糖果或甜饮料即可纠正,如仍不见效,应立即就医。少数严重者可静脉给葡萄糖。|5.胃肠反应一般为暂时性的,随着治疗继续而消失,一旦有皮肤过敏反应,应停用本品,代之以其他降糖药或胰岛素。

贮藏

遮光,密封保存。

规格

30mg

证据Evidence

  • 批准文号: 国药准字H20123059
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.